Webinars

4th Annual Next Gen Immuno-Oncology Virtual Congress: Humanized Immune Checkpoint Mice Improve Translatability of Novel Immunotherapies

Biocytogen’s humanized CD3E & CD3EDG models allow for broader targeting of the entire CD3 complex with novel mono- & bispecific antibody therapeutics.

Read more

AET Europe 2021: Powerful Engine for Therapeutic Antibody Discovery – RenMab/RenLite Immunoglobulin Humanized Mouse Platform

Learn more about Biocytogen’s established first and second generation of immunoglobulin humanized mouse platforms: RenMab and RenLite.

Read more

FcRn Therapies 2021 Conference: Humanized Mouse Models to Assess the In Vivo Efficacy of Antibody Therapeutics

Learn about the powerful models of Humanized mouse in IL4/IL4RA and IL-17 mice in various in-vivo settings

Read more

AET Europe 2020: Advancing Therapeutic Antibody discovery using RenMab/RenLite/RenMab KO immunoglobulin humanized mouse platforms

To meet the expanding needs of the therapeutic antibody market, Biocytogen established first and second generation of immunoglobulin humanized mouse platforms: RenMab, RenMab KO and RenLite.

Read more

IO Summit Boston: Improve Translation of Humanized Animal Models for Immunotherapy

Learn about the new developments in humanized animal models to get ideas on how models can be applied to solve specific translational challenges.

Read more

Accelerating Therapeutic Antibody Discovery with Three Distinct Humanized Mouse Models

With a robust immune response, RenMab™ Mouse produces fully-human, functional antibodies of high antigen specificity and diverse epitopes.

Read more